Characterization of CD4 T Cells in Type 1 Diabetes

Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control Individuals

Recruiting N/A Interventional Study
Type 1 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 – 18
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
80 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Who this trial is looking for

This trial is looking for young people with newly diagnosed Type 1 diabetes and healthy individuals to compare their immune cells. Participants will have their blood sampled to help researchers understand the disease better.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 2 and 18 years old
  • I weigh at least 12 kg
  • I have been diagnosed with Type 1 diabetes
  • I am a member of a health insurance scheme
  • I can understand and read French
  • I have parental consent

You may not be able to join if

  • I have used corticosteroids in the past month
  • I cannot use anaesthetic cream for blood sampling
  • I have any other inflammatory or autoimmune disease

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Type 1 diabetes (T1D) is caused by an autoimmune response leading to the destruction of pancreatic beta cells. The disease association with particular HLA class II alleles, particularly HLA-DQ8, indicates the implication of CD4 T cells in its aetiology. The hypothesis is therefore that T1D starts by the loss of tolerance in autoreactive CD4 T cells. This might result from alterations in convention…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Newly diagnosed T1DM group: * Age ≥ 2 years and \< 18 years on day of inclusion; * Weight ≥ 12 kg; * Newly diagnosed T1DM, diagnosis defined according to International Society of Pediatric and Adolescent Diabetes (ISPAD) criteria by: hyperglycemia \> 2g/L and/or ketonemia and/o…
Contacts

Jacques BELTRAND, MD, PhD

+33 1 40 61 53 20

jacques.beltrand@aphp.fr

CONTACT

Sarah BOUCHARD

+ 33 1 42 19 28 79

sarah.bouchard@aphp.fr

CONTACT